Veerle Janssens

Leuven, VLG 3000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Protein phosphatase 2 phosphatase activator (PTPA) promotes oncogene-induced senescence and carboplatin response in human malignant pleural mesothelioma cells.

Protein phosphatase 2 phosphatase activator (PTPA) promotes oncogene-induced senescence and carboplatin response in human malignant pleural mesothelioma cells.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 22, 2025

Houge-Janssens syndrome.

Houge-Janssens syndrome.

Journal: European journal of human genetics : EJHG

Published: March 14, 2025

The phosphatase activity of the PPP2R5D-PP2A holoenzyme modulates liprin-α1 liquid-liquid phase separation.

The phosphatase activity of the PPP2R5D-PP2A holoenzyme modulates liprin-α1 liquid-liquid phase separation.

Journal: The Journal of biological chemistry

Published: February 05, 2025

Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum.

Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum.

Journal: American journal of human genetics

Published: August 27, 2024

The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme.

The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme.

Journal: bioRxiv : the preprint server for biology

Published: July 01, 2024

The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism.

The PPP2R1A cancer hotspot mutant p.R183W increases clofarabine resistance in uterine serous carcinoma cells by a gain-of-function mechanism.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: May 29, 2024

PPP2R5E: New gene potentially involved in specific learning disorders and myopathy.

PPP2R5E: New gene potentially involved in specific learning disorders and myopathy.

Journal: Gene

Published: May 14, 2024

PP2A phosphatase regulatory subunit PPP2R3C is a new positive regulator of the hedgehog signaling pathway.

PP2A phosphatase regulatory subunit PPP2R3C is a new positive regulator of the hedgehog signaling pathway.

Journal: Cellular signalling

Published: February 25, 2024

TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer.

TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 23, 2023

PME-1-regulated neural cell death: new therapeutic opportunities?

PME-1-regulated neural cell death: new therapeutic opportunities?

Journal: Aging

Published: August 26, 2023

A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d.

A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d.

Journal: Cancers

Published: July 14, 2023

PME-1 sensitizes glioblastoma cells to oxidative stress-induced cell death by attenuating PP2A-B55α-mediated inactivation of MAPKAPK2-RIPK1 signaling.

PME-1 sensitizes glioblastoma cells to oxidative stress-induced cell death by attenuating PP2A-B55α-mediated inactivation of MAPKAPK2-RIPK1 signaling.

Journal: Cell death discovery

Published: June 22, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026